Abstract
Insulin Resistance (IR) is a physiological condition in which pancreatic cells fail to respond to normal actions of insulin hormone. It is a milestone for the development of diabetes and its complications. The current approach for the treatment of the diabetes and insulin resistance includes pharmacotherapeutics. However, this therapy includes the development of drug tolerance, potential toxicity and inadequate relief warranting the investigation of newer approaches for treatment. A potentially safe and effective therapeutic treatment for insulin resistance (IR) in diabetes is required. The current research is focused on herbal or phytochemical drugs. The potential herbal targets with insulin mimetic, secretagogues and promising activity are under the scope of this review. In this review, we have discussed the herbal targets and non-pharmacological approaches for the treatment of IR in diabetes. This review aims to compile the relevant information regarding various phases of drug development for the management of the insulin resistance and highlight the future prospective for its treatment by natural and semi-synthetic drugs.
Keywords: Diabetes, insulin resistance, semi-synthetic drugs, treatment, pharmacotherapeutics, natural drugs.
Current Psychopharmacology
Title:Insulin Resistance in Diabetes: Present and Future Prospective of Treatment
Volume: 7 Issue: 2
Author(s): Anil Kumar*, Ruchika Mittal and Ashmeen Kaur
Affiliation:
- Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh,India
Keywords: Diabetes, insulin resistance, semi-synthetic drugs, treatment, pharmacotherapeutics, natural drugs.
Abstract: Insulin Resistance (IR) is a physiological condition in which pancreatic cells fail to respond to normal actions of insulin hormone. It is a milestone for the development of diabetes and its complications. The current approach for the treatment of the diabetes and insulin resistance includes pharmacotherapeutics. However, this therapy includes the development of drug tolerance, potential toxicity and inadequate relief warranting the investigation of newer approaches for treatment. A potentially safe and effective therapeutic treatment for insulin resistance (IR) in diabetes is required. The current research is focused on herbal or phytochemical drugs. The potential herbal targets with insulin mimetic, secretagogues and promising activity are under the scope of this review. In this review, we have discussed the herbal targets and non-pharmacological approaches for the treatment of IR in diabetes. This review aims to compile the relevant information regarding various phases of drug development for the management of the insulin resistance and highlight the future prospective for its treatment by natural and semi-synthetic drugs.
Export Options
About this article
Cite this article as:
Kumar Anil *, Mittal Ruchika and Kaur Ashmeen , Insulin Resistance in Diabetes: Present and Future Prospective of Treatment, Current Psychopharmacology 2018; 7(2) . https://dx.doi.org/10.2174/2211556007666180309155102
DOI https://dx.doi.org/10.2174/2211556007666180309155102 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
Current Pharmaceutical Design Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Current Drug Targets Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs
Current Pharmacogenomics Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives
Medicinal Chemistry The Targets of Curcumin
Current Drug Targets Synthesis and Biological Evaluation of 2´-Hydroxy-4´,6´-Diprenyloxychal-Cone Derivatives as Potent CDC25B and PTP1B Inhibitors
Letters in Drug Design & Discovery Polysaccharide-Protein Nanoassemblies: Novel Soft Materials for Biomedical and Biotechnological Applications
Current Protein & Peptide Science Azelaic Acid: A Promising Agent for Dermatological Applications
Current Drug Therapy Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
Current Alzheimer Research Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology Proteomic Analysis of Glucose-Induced Cardiac Myoblasts and the Potential Role of mir-92b-5p in Regulating Sarcomere Proteins Under a Hyperglycemic Environment
Protein & Peptide Letters Activation of the dsRNA-Activated Protein Kinase PKR in Mitochondrial Dysfunction and Inflammatory Stress in Metabolic Syndrome
Current Pharmaceutical Design Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry Pegylated Fluorescent Peptides as Substrates of Proteolytic Enzymes
Protein & Peptide Letters Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry “Metabolic Aspects” In Inflammatory Bowel Diseases
Current Drug Delivery α-Glucosidase Inhibitory Activity of the Extracts and Major Phytochemical Components of Smilax glabra Roxb
The Natural Products Journal Peroxisome Proliferator-Activated Receptors: The Nutritionally Controlled Molecular Networks that Integrate Inflammation, Immunity and Metabolism
Current Nutrition & Food Science Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design